AAPL - Dow Jones Tumbles as Apple Stock Rises on Price Target Bump Salesforce Stock Slumps on Expected Slack Acquisition
The Dow Jones Industrial Average (DJINDICES: ^DJI) couldn't hold it together on Monday, slumping about 0.89% by 10:05 a.m. EST. The COVID-19 vaccine situation improved after Moderna released the full results of its phase 3 study, but the news wasn't enough to propel the markets higher. Moderna found a vaccine efficacy of 94.1% against COVID-19, with an efficacy of 100% against severe COVID-19 cases.
Shares of Apple (NASDAQ: AAPL) got a boost after receiving an analyst price target increase on 5G upgrade optimism. Meanwhile, shares of salesforce.com (NYSE: CRM) slumped on a report that the company's acquisition of Slack (NYSE: WORK) is coming tomorrow.
Image source: Getty Images.
For further details see:
Dow Jones Tumbles as Apple Stock Rises on Price Target Bump, Salesforce Stock Slumps on Expected Slack Acquisition